Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 1-2, 2017

Issue release date: February 2017

Add all to MyReading List
Beilage

Konsensusempfehlungen deutscher Experten - Management der Therapie mit Idelalisib

Oncol Res Treat 2017;40:I (DOI:10.1159/000458426)
Free Access
 
1

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:1-6 (DOI:10.1159/000456628)
Free Access
Original Article
7

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Igawa S. · Ryuge S. · Ichinoe M. · Nakashima H. · Otani S. · Nakahara Y. · Fukui T. · Sasaki J. · Kubota M. · Katagiri M. · Murakumo Y. · Satoh Y. · Sato Y. · Masuda N.
Oncol Res Treat 2017;40:7-13 (DOI:10.1159/000455147)
15

Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer

Wan Y.-P. · Xi M. · He H.-C. · Wan S. · Hua W. · Zen Z.-C. · Liu Y.-L. · Zhou Y.-L. · Mo R.-J. · Zhuo Y.-J. · Luo H.-W. · Jiang F.-N. · Zhong W.-D.
Oncol Res Treat 2017;40:15-20 (DOI:10.1159/000455145)
21

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

Quidde J. · Denne L. · Kutscheidt A. · Kindler M. · Kirsch A. · Kripp M. · Petersen V. · Schulze M. · Seraphin J. · Tummes D. · Arnold D. · Stein A.
Oncol Res Treat 2017;40:21-26 (DOI:10.1159/000454774)
27

Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement

Lin D. · Zeng D. · Chen C. · Wu X. · Wang M. · Chen J. · Lin H. · Qiu X.
Oncol Res Treat 2017;40:27-33 (DOI:10.1159/000454715)
35

Significance of Vasculogenic Mimicry Formation in Gastric Carcinoma

Lv J. · Sun B. · Sun H. · Zhang Y. · Sun J. · Zhao X. · Gu Q. · Dong X. · Che N.
Oncol Res Treat 2017;40:35-41 (DOI:10.1159/000455144)
42

Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy

Ikezaki T. · Suzuki K. · Kambara K. · Inomata M. · Okazawa S. · Kajiura S. · Miwa T. · Tanabe K. · Kashii T.
Oncol Res Treat 2017;40:42-45 (DOI:10.1159/000455255)
Novel Insights from Clinical Practice
46

A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy

Schmit J.M. · DeLaune J. · Norkin M. · Grosbach A.
Oncol Res Treat 2017;40:46-48 (DOI:10.1159/000455146)
 
50

Society Bulletins

Oncol Res Treat 2017;40:50-56 (DOI:10.1159/000455438)
Free Access
57

PharmaForum

Oncol Res Treat 2017;40:57 (DOI:10.1159/000456700)
Free Access
58

PharmaForum

Oncol Res Treat 2017;40:58-61 (DOI:10.1159/000456701)
Free Access
63

PharmaNews

Oncol Res Treat 2017;40:63 (DOI:10.1159/000456702)
Free Access
64

PharmaNews

Oncol Res Treat 2017;40:64-68 (DOI:10.1159/000456703)
Free Access
70

Meetings and Conferences

Oncol Res Treat 2017;40:70-71 (DOI:10.1159/000456626)
Free Access